# US 2019/0167717 A1 · Methods for treating skin irritation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0167717 A1
- Document ID: US20190167717A1
- Status: Published application
- Kind: A1
- Application number: 16/173,691
- Filed: 2018-10-29
- Published: 2019-06-06
- Earliest claimed: 2011-03-18
- Assignees: Realm Therapeutics, Inc.
- Applicants: Realm Therapeutics, Inc.
- Inventors: Mark SAMPSON; Svetlana PANICHEVA; Cary SCHOCKEMOEHL; Gerard DIBELLO; Vadim PANICHEV
- Web page: https://patentgrep.com/patent/US20190167717A1

## CPC

- A61K 33/20: Elemental chlorine; Inorganic compounds releasing chlorine
- A01N 59/00: Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N 59/08: Alkali metal chlorides; Alkaline earth metal chlorides
- A23B 2/788: Inorganic compounds
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 33/10: Carbonates; Bicarbonates
- A61K 47/02: Inorganic compounds
- B65D 65/38: Packaging materials of special type or form
- B65D 2565/387: Materials used as gas barriers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A01N: PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF (preservation of food or foodstuff A23); BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES (preparations for medical, dental or toiletry purposes which kill or prevent the growth or proliferation of unwanted organisms A61K); PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A23B: PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- B65D: CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES

## Abstract

The present invention provides a stabilized hypohalous acid solution (or formulation thereof), which may be conveniently packaged for sale, or stored for later use on demand. The invention further provides methods of making the stabilized hypohalous acid solutions, as well as methods of use for disinfecting mammalian tissue, including wounds and burns, and treating skin irritations, among other uses.

## Claims

### Claim 1

A method for treating an irritation of the skin of a subject, comprising: administering a hypochlorous acid composition to the affected area, wherein the composition has an available free chlorine (AFC) content of from about 100 to about 1000 ppm and is stabilized by dissolved inorganic carbon within a pH of from about 4 to about 7.5.

### Claim 2 (depends on 1)

The method of claim 1, wherein the irritation is characterized by an inflammatory reaction or hyperinflammation of the skin.

### Claim 3 (depends on 2)

The method of claim 2, wherein the subject has atopic dermatitis, skin allergy, rosasea, psoriasis, acne, Selective IgM Deficiency, pemphigus, erythema multiforme, bullous disease of the skin, or dermatitis herpetiformis.

### Claim at position 4

4-6. (canceled)

### Claim 7 (depends on 2)

The method of claim 2, wherein the subject has a type I hypersensitivity reaction.

### Claim 8 (depends on 7)

The method of claim 7, wherein the type I hypersensitivity reaction manifests in one or more of itching or hives.

### Claim 9 (depends on 2)

The method of claim 2, wherein the subject has a type IV hypersensitivity reaction.

### Claim 10 (depends on 9)

The method of claim 9, wherein the subject has Sjogrren's Syndrome, Sarcoidosis, or contact dermatitis.

### Claim 11 (depends on 2)

The method of claim 2, wherein the subject has a drug reaction or transplant rejection.

### Claim 12 (depends on 1)

The method of claim 1, wherein the irritation accompanies a bacterial or viral infection.

### Claim 13 (depends on 1)

The method of claim 1, wherein the patient has a skin fungal infection, an autoimmune reaction, lymphoma, or an inheritable disorder.

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16 (depends on 13)

The method of claim 13, wherein the inheritable disorder is Dystrophic Epidermolysis Bullosa, Hisrontic Ectodermal Dysplasia, or palmoplantar hyperkeratosis.

### Claim 17

(canceled)

### Claim 18 (depends on 13)

The method of claim 13, wherein the lymphoma is Cutaneous T-Cell Lymphoma (CTCL).

### Claim 19 (depends on 1)

The method of claim 1, wherein the hypochlorous acid composition is created by a process that comprises electrolysis of saline.

### Claim 20 (depends on 1)

The method of claim 1, wherein the hypochlorous acid composition has an AFC content of from about 100 ppm to about 500 ppm.

### Claim 21 (depends on 1)

The method of claim 1, wherein the hypochlorous acid composition has a pH of from 4.4 to 7.

### Claim 22 (depends on 1)

The method of claim 1, wherein the hypochlorous acid composition has a pH of from 5 to 7

### Claim 23 (depends on 1)

The method of claim 1, wherein the dissolved inorganic chloride (DIC) is present at a molar ratio of from 5:1 to 1:5 with respect to the AFC content.

### Claim 24 (depends on 1)

The method of claim 1, wherein the hypochlorous acid composition contains 300 to 1500 mg/L of a carbonate or bicarbonate salt.

### Claim 25 (depends on 1)

The method of claim 1, wherein the hypochlorous acid composition is a cream, foam, or hydrogel.

### Claim 26 (depends on 1)

The method or claim 1, wherein the hypochlorous acid composition is provided in a packaging with minimal gas permeability.

### Claim at position 25

27-35. (canceled)
